Antibody reagent kits
Closed Solicitation Posted
- Solicitation number
- SS-NIAID-25-2244688
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Bethesda, Maryland 20892, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, is seeking sources for domestically manufactured Antibody Reagent Kits through a Sources Sought notice. The procurement focuses on specific antibody purification kits and related laboratory reagents, including detailed specifications for protein purification components and various antibody types such as anti-CD3 zeta, BTK, Phospholipase C gamma 1, and Syk antibodies. Interested vendors must demonstrate capability to produce these products entirely within the United States, in compliance with the Buy American Act and Executive Order 14005. Vendors are required to submit a comprehensive capability statement by December 10, 2024, at 12:00 PM EST through the NIAID electronic Simplified Acquisition Submission System (eSASS). The capability statement must include organizational details, contact information, active SAM.gov registration, and specific documentation proving domestic manufacturing capacity.
The solicitation does not include a specific set-aside designation and does not indicate a predetermined award value or contract budget. The place of performance is identified as Bethesda, MD 20892, with the procurement falling under NAICS category 325414 for Biological Product Manufacturing and PSC category 6505 for Drugs and Biologicals. Respondents are explicitly advised that this sources sought notice does not guarantee a contract award and serves primarily to assess market capabilities for potential future solicitation. The government reserves the right to use submitted non-proprietary information in subsequent procurement documents. Vendors must ensure their submissions are detailed enough to demonstrate qualifications but should not include any proprietary, classified, or sensitive information. After reviewing responses, NIAID may publish a pre-solicitation synopsis and subsequent formal solicitation through Federal Business Opportunities.
Notice text
This is a Sources Sought notice for domestically manufactured products only. This is NOT a solicitation for proposals, proposal abstracts, or quotations. Per the Buy American Act and Executive Order 14005, the National Institutes of Allergy & Infectious Disease (NIAID) is seeking information for domestically manufactured products only, Per the requirements under the Buy American Act and requirements relating to Executive Order 14005 entitled: “Ensuring the Future is Made in All of America by All of America’s Workers”, in the event that a nonavailability waiver request submitted through the Made in America Office (MIAO)’s Digital Waiver Portal is required." Respondents must certify in capabilities statement that products are manufactured in the United States.
The purpose of this notice is to obtain information regarding the availability and capability of all U.S manufactured products that meet the following requirements:
Antibody Purification Kit (Protein A)
Additional Collecting Tubes 12 x 1 Via l
Binding Buffer (10X) 1 x 200 µL
Elution Buffer 1 x 1500 µL
Neutralizer Buffer 1 x 500 µL
Protein Aresin 3 x 100 µL
Spin Cartridge/Collecting Tube assemblies 3 x 1
Unit Wash Buffer 1 x 12 m L 2
Anti-CD3 zeta (phospho Y142) antibody [EP265(2)Y] - BSA and Azide free
Isotype IgG
Host species Rabbit
Storage buffer pH: 7.2 - 7.4 Constituents: PBS
Form Liquid
Clonality Monoclonal
BTK (phospho Y223) antibody [EP420Y] - BSA and Azide free
Operating system Embedded operating system
Measurement parameters Area, width, height for all parameters, with time and volume
Signal processing >18 bit dynamic range in area with 32 bit floating point signal processing
Compensation Automated, or manual with 14×14 matrix, during or after acquisition
Data files .mqd (proprietary file format), .fcs (2.0, 3.0, 3.1 compatible)
Anti-Phospholipase C gamma 1/PLC-gamma-1 (phospho Y783) antibody [EPR2611Y] - BSA and Azide free
Isotype IgG
Host species Rabbit
Storage Buffer pH: 7.2 - 7.4 Co n stitu e n ts: PBS
Form Liquid
Clonality Monoclonal
Anti-Syk (phospho Y352) +ZAP70 (phospho Y319) antibody [EPR26232-39] - BSA and Azide free
Isotype IgG
Host species Rabbit
Storage buffer pH: 7.2 - 7.4 Constituents: 100% PBS
Form Liquid
Clonality Monoclonal
Capability Statement/Information Sought
All capable vendors should respond with a brief capability statement demonstrating a product that meets the above requirements that are manufactured in the United States by December 10, 2024, by 12:00 PM EST. Country of origin MUST be included in the capability statement. Capabilities statement must also include the following information: 1) organization name, address, point of contact, email address, website address, telephone number, UE ID# with an active SAM.gov registration, and a tailored capability statements addressing the particulars of this effort, with appropriate documentation supporting claims of capability.
Submission Instructions
Interested businesses who consider themselves qualified to provide the above-listed items are invited to submit a response to this Sources Sought Notice by December 10, 2024, at 12:00 PM EST. All responses under this Sources Sought Notice must be submitted via the NIAID electronic Simplified Acquisition Submission System (eSASS) website at https://esass.nih.gov. All vendors must register in the eSASS system to submit their documentation. Instructions on how to register /submit documents are included on the website. All responses received by the closing date of this synopsis will be considered by the Government.
Disclaimer and Important Notes
This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a presolicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation. 4
Confidentiality
No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s)
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity